Aligos

formerly Aligos TherapeuticsIPO

Home - ALIGOS Therapeutics

South San Francisco, United States · Founded 2018 · $230.0M raised

Employees
51–200
Founded
2018
Website
aligos.com
Total Funding
$230.0M
Last Round
$105.0M Venture RoundFeb 2025
Rounds
2

About

Aligos is a clinical-stage biotechnology company developing therapies for liver and viral diseases. Its science-driven pipeline addresses high unmet-need conditions including chronic hepatitis B virus infection and metabolic dysfunction-associated steatohepatitis (MASH). The company applies hepatology and virology expertise to advance purpose-built drug candidates intended to improve patient outcomes.

Summary

Aligos is a Biotech company based in South San Francisco, United States, founded in 2018. It has raised $230.0M in total across 2 rounds, most recently a $105.0M Venture Round round in Feb 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundPrivate Placement FinancingFeb 2025
$105.0M

Sign up to see all 3 rounds

Series B through Venture Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aligos on Indexed.vc
<a href="https://indexed.vc/companies/aligos"><img src="https://indexed.vc/api/badge/company/aligos" alt="Aligos on Indexed.vc" width="260" height="76" /></a>